Many researchers have reported that the high expression of KIF5A was associated with poor clinicopathological characteristics and prognosis of solid tumors such as breast cancer [8], prostate cancer [9], and lung cancer [10]. This evidence concerns the gene KIF5A and breast carcinoma.